Nvax earnings report
Web10 feb. 2024 · Earnings ESP: Novavax’s Earnings ESP is 0.00% as both the Most Accurate Estimate and Zacks Consensus Estimate stand at a loss of $1.27 per share.
Nvax earnings report
Did you know?
Web1 mrt. 2024 · But analysts are mixed on 2024 expectations for Novavax. They call for $4.99 per share in losses. That would diminish from an $8.42 per-share loss in 2024. But they … Web10 apr. 2024 · NVAX’s grants revenue decreased 26.8% year-over-year to $69.57 million for the fourth quarter that ended December 31, 2024. Its total current assets came in at $1.70 billion for the period that ended December 31, 2024, compared to $2.16 billion for the period that ended December 31, 2024.
Web9 mei 2024 · Adjusted earnings: $2.56 per share, vs. $2.69 expected. Revenue: $704 million, vs. $845 million expected. The FDA’s committee of independent advisors is set to … Web2 dagen geleden · The company’s shares started off the day by climbing as high as $9.31 per share. For comparison, the stock closed out trading yesterday at $9.04 per share. Unfortunately for NVAX investors, it couldn’t maintain that price and is now trading for about $8.94 per share. That represents a 1.1% drop from yesterday’s close.
Web13 apr. 2024 · Novavax Inc (NVAX) stock is trading at $9.27 as of 10:55 AM on Thursday, Apr 13, a gain of $0.23, or 2.54% from the previous closing price of $9.04. The stock has traded between $8.97 and $9.33 so far today. Volume today is below average. So far 1,163,743 shares have traded compared to average volume of 6,704,663 shares. WebCheck earnings reports and economic data . U.S. Economy . Be the first to grasp macro changes . Topics . Explore trending topics in investing and business . Moo Community . Feed . Find inspiration for your next move . Topics . Discuss hot topics with like-minded traders . Learn . Courses . Everything you need to learn about investing . Strategies;
Web12 apr. 2024 · Novavax, Inc. has a 12-month low of $5.61 and a 12-month high of $76.77. The firm has a market capitalization of $778.98 million, a P/E ratio of -1.08 and a beta of 1.73. The stock's fifty day simple moving average is $8.11 and its 200-day simple moving average is $13.33. Novavax ( NASDAQ:NVAX - Get Rating) last posted its quarterly …
WebUnited States NVAX Finanicals Stock Screener Earnings Calendar Sectors Nasdaq NVAX U.S.: Nasdaq Novavax Inc. Watch list Create NVAX Alert Premarket Last Updated: Mar … lymphoepithelial carcinoma treatmentWeb24 okt. 2024 · We expect investors to focus on the sales performance of Novavax, Inc.’s NVAX protein-based COVID-19 vaccine, NVX-CoV2373, its sole marketed product, … king years and years youtubeWeb10 apr. 2024 · The average price estimated by analysts for NVAX is $50.80, which is $42.34 above than the current price. The public float for NVAX is 78.14M, and at present, short sellers hold a 42.54% of that float. The average trading volume of NVAX on April 10, 2024 was 6.38M shares. Top 5 AI Stocks to Buy for 2024 king yen 2 southwick ma menuWeb9 aug. 2024 · Novavax (NVAX) delivered earnings and revenue surprises of 0.00% and 4.85%, respectively, for the quarter ended June 2024. ... Novavax (NVAX) Reports Q2 … lymphoepithelial sialadenitis pathologyWeb1 dag geleden · Dow Jones dips as JPMorgan earnings beat, along with other banks. Boeing 737 woes hit BA stock. ... The Federal Reserve is expected to report March industrial production at 9:15 a.m. ET. lymphoepithelial cyst pharynxWeb10 apr. 2024 · Apr. 10, 2024 7:10 AM ET Novavax, Inc. (NVAX) 2 Comments. SA Transcripts. 135.79K Follower s. The following slide deck was published by Novavax, Inc. in conjunction with this event. View as PDF ... king y countryWebFind the latest NVAX230414C00008000 (NVAX230414C00008000) stock quote, history, news and other vital information to help you with your stock trading and investing. lymphoepithelial cyst floor of mouth